personalized medicine

GenomeDx will test its Decipher GRID database of cancer genomic profiles with samples from Janssen-run prostate cancer clinical trials.

The companies are aiming to develop and establish clinical operation for the assays in Japan, where Hitachi said there is growing demand for such tests.

The companies will join their respective technologies into a precision oncology testing and analysis offering.

The funding will support various projects and research centers that are advancing precision medicine and genomic technology development.

Theradiag's Lisa Tracker monitoring kits will be referenced in supply contracts for Merck's immunosuppressant drug.

The companies will develop a platform for sample and workflow management, genetic data interpretation, and external client communication.

The companies will combine their respective technologies to develop epigenetic assays for cancer patient stratification and personalized treatment.

The company will use the money to bring its Elsie genomic information platform to markets internationally.

Philips and its partners aim to combine liquid biopsy with magnetic resonance imaging to enable personalized cancer treatment.